Filter by:
Apr 292020
Neuraptive Therapeutics Announces FDA Clearance of IND Application

NTX-001 is a potentially transformative adjunctive treatment for peripheral nerve injuries, using a propriety system for the reconnection of severed…

Continue Reading
Feb 202020
New Rhein – Belgium Investor Day (March 9, 2020)

New Rhein Healthcare Investors invites you to join us for our event, Investing in Healthcare and Life Science Innovations, in Ghent, Belgium, on…

Continue Reading
Jun 132019
New Rhein Hosts First Industry Day During Philadelphia BIO Event

  PHILADELPHIA, June 10, 2019 /PRNewswire/ -- New Rhein Healthcare Investors, a Philadelphia based private equity manager focused on healthcare therapeutics and medical devices,…

Continue Reading
Apr 222019
New Rhein Healthcare Inaugural Industry Day

New Rhein announces it's Inaugural Industry Day 2019! The event will include company presentations and fireside chats with senior pharma…

Continue Reading
Dec 192018
Neuraptive Therapeutics Raises $11.5M Series A

LAFAYETTE, Colo., Dec. 19, 2018 /PRNewswire/ -- Neuraptive Therapeutics, Inc. (Neuraptive) announced today that it has secured a $11.5 million Series A equity financing which remains…

Continue Reading